东亚药业: 东亚药业第四届监事会第七次会议决议公告

Group 1 - The meeting of the fourth supervisory board of Zhejiang Dongya Pharmaceutical Co., Ltd. was held on May 30, 2025, in accordance with relevant laws and regulations [1][2] - The supervisory board approved the proposal to postpone the investment project funded by convertible bonds, stating that the decision was made based on the actual situation of the project and did not harm the interests of shareholders or the company [1][2] - The voting results showed unanimous support for the proposal, with 3 votes in favor and no votes against or abstentions [2]